The K@W Network:
Henry Bower Professor Emeritus of Management
Johnson & Johnson has been accused of ignoring warnings linking its talcum powder to ovarian cancer and failing to inform users of that potential risk. Is it a case of[…]
Xerox’s split into two companies unravels its 2009 merger with Affiliated Computer Services. Will the spinoff prove any more successful than the decision to merge in the first place?
With several of its blockbuster drugs coming off patent, Pfizer's acquisition of Allergan would strengthen its pipeline with drugs aimed at specialty markets such as cosmetics and dermatology.
How can a new pope attract new groups -- and generations -- without alienating historically important demographics?
Mergers and acquisitions activity is hitting record heights. Multibillion-dollar deals abound, with companies scrambling to combine as the Fed prepares to raise interest rates this year.